FTC says Shire unit used illegal tactics to block generic competition
February 07, 2017 at 15:01 PM EST
The suit, filed in Delaware federal court on Tuesday, targets ViroPharma, which was acquired by the Irish drugmaker in November 2013 for $4.2 billion.
